Malignant melanoma is a neoplasm of melanocytes, and the microphthalmia‐associated
transcription factor (MITF) is essential for the existence of melanocytes. MITF's relevance for …

MITF (microphthalmia-associated transcription factor) represents a melanocytic lineage-
specific transcription factor whose role is profoundly extended in malignant melanoma. Over …

Microphthalmia-associated transcription factor (MITF) acts as a master regulator of
melanocyte development, function and survival by modulating various differentiation and …

Various environmental and genetic factors affect the development and progression of skin
cancers including melanoma. Melanoma development is initially triggered by environmental …

Microphthalmia-associated transcription factor (MITF) is an important regulator of
melanogenesis and melanocyte development. Although it has been studied extensively in …

Melanoma is a therapy-resistant skin cancer due to numerous mechanisms supporting cell
survival. Although components of melanoma cytoprotective mechanisms are overexpressed …

The microphthalmia-associated transcription factor (MITF) is the “master melanocyte
transcription factor” with a complex role in melanoma. MITF protein levels vary between and …

Malignant melanoma is a chemotherapy‐resistant cancer with high mortality. Recent
advances in our understanding of the disease at the molecular level have indicated that it …

Purpose: The microphthalmia-associated transcription factor (MITF) is regarded as a key
oncogene of the melanocytic lineage since it was detected by a genome-wide analysis to be …

The Microphthalmia-associated transcription factor (MITF) is an important regulator of cell-
type specific functions in melanocytic cells. MITF is essential for the survival of pigmented …